Insulin Upregulates PKM2 Expression But Inhibits its Activity to Promote Cancer Cell Metabolism

被引:0
|
作者
Iqbal, M. A. [1 ]
Bamezai, R. N. K. [1 ]
机构
[1] Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi 110067, India
关键词
D O I
10.1016/S0959-8049(12)71169-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
503
引用
收藏
页码:S120 / S120
页数:1
相关论文
共 50 条
  • [21] Insulin promotes hepatocarcinoma tumorigenesis by up-regulating PKM2 expression
    Liu, Jingjing
    Zhi, Qiang
    Liu, Yunpeng
    Wang, Ying
    Chen, Linlin
    Ke, Yuhao
    Zeng, Lingsu
    Wu, Xiaoling
    Yang, Xiaoning
    Guleng, Bayasi
    Liu, Hao
    Ren, Jianlin
    EXPERIMENTAL CELL RESEARCH, 2021, 408 (02)
  • [22] N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity
    Pagano, Cristina
    Coppola, Laura
    Navarra, Giovanna
    Avilia, Giorgio
    Savarese, Beatrice
    Torelli, Giovanni
    Bruzzaniti, Sara
    Piemonte, Erica
    Galgani, Mario
    Laezza, Chiara
    Bifulco, Maurizio
    FEBS OPEN BIO, 2024, 14 (05): : 843 - 854
  • [23] PolG Inhibits Gastric Cancer Glycolysis and Viability by Suppressing PKM2 Phosphorylation
    Lv, Mengzhu
    Zhang, Simeng
    Dong, Yuqing
    Cao, Liu
    Guo, Shu
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1559 - 1570
  • [24] Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling
    Xie, Xinhua
    Huangi, Xiaojia
    Tangi, Hailin
    Ye, Feng
    Yang, Lu
    Guo, Xiaofang
    Tian, Zhi
    Xie, Xiaofang
    Peng, Cheng
    Xie, Xiaoming
    CURRENT CANCER DRUG TARGETS, 2018, 18 (06) : 592 - 599
  • [25] EXPRESSION OF PKM2 IN NSCLC AND ITS CORRELATION WITH CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS
    Yang, WenRong
    Chen, Lin
    Cha, Jianyuan
    Ping, Xiaying
    Li, Zhuang
    Li, Aimin
    Yang, Lijie
    ACTA MEDICA MEDITERRANEA, 2020, 36 (01): : 29 - 33
  • [26] Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession
    Yuan-Rong Liu
    Dan-Dan Song
    Dong-Min Liang
    You-Jie Li
    Yun-Fei Yan
    Hong-Fang Sun
    Mei-Ling Zhang
    Jin-Xia Hu
    Yu-Long Zhao
    Yan Liang
    Yan-Mei Li
    Zhen Yang
    Ran-Ran Wang
    Hou-Feng Zheng
    Pingyu Wang
    Shu-Yang Xie
    Cell Death Discovery, 8
  • [27] Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession
    Liu, Yuan-Rong
    Song, Dan-Dan
    Liang, Dong-Min
    Li, You-Jie
    Yan, Yun-Fei
    Sun, Hong-Fang
    Zhang, Mei-Ling
    Hu, Jin-Xia
    Zhao, Yu-Long
    Liang, Yan
    Li, Yan-Mei
    Yang, Zhen
    Wang, Ran-Ran
    Zheng, Hou-Feng
    Wang, Pingyu
    Xie, Shu-Yang
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [28] The role of PKM2 in cancer progression and its structural and biological basis
    Bingxin Wu
    Zuhui Liang
    Huan Lan
    Xiaojun Teng
    Caiyan Wang
    Journal of Physiology and Biochemistry, 2024, 80 : 261 - 275
  • [29] Pkm2 can enhance pluripotency in ESCs and promote somatic cell reprogramming to iPSCs
    Qin, Shengtang
    Yang, Danli
    Chen, Kang
    Li, Haolan
    Zhang, Liqiang
    Li, Yuan
    Le, Rongrong
    Li, Xiaojie
    Gao, Shaorong
    Kang, Lan
    ONCOTARGET, 2017, 8 (48) : 84276 - 84284
  • [30] Roles for Pkm1 and Pkm2 in non-small cell lung cancer
    Nomura, Miyuki
    Sato, Taku
    Morita, Mami
    Sakamoto, Yoshimi
    Tanaka, Ryota
    Miura, Koh
    Kawai, Masaaki
    Sato, Ikuro
    Shima, Hiroshi
    Tanuma, Nobuhiro
    CANCER SCIENCE, 2018, 109 : 259 - 259